Cap
Bid
Ask
/product/detail/index/isin/CH0211017139
21101713 
Nestlé71.64 CHF109.50%39.24%100% 30.07.2018CHF78.7879.21
/product/detail/index/isin/CH0218000468
21800046LOKB6
S&P 500 Index1'707.14 USD100.00%62.30%100% 06.08.2018USD2'861.002'878.00
/product/detail/index/isin/CH0226957105
22695710PPSLA
Swiss Re107.21 CHF148.00%51.10%100% 23.10.2018CHF116.60117.50
/product/detail/index/isin/CH0226957121
22695712PPSLB
Swiss Re107.28 CHF148.00%51.07%100% 24.10.2018CHF116.70117.60
/product/detail/index/isin/CH0226957147
22695714PPSLC
Swiss Re107.75 CHF148.00%50.84%100% 25.10.2018CHF117.20118.10
/product/detail/index/isin/CH0239303453
23930345 
Roche298.65 CHF115.00%19.96%100% 18.06.2019CHF281.82284.65
/product/detail/index/isin/CH0240229663
24022966 
Roche289.52 CHF110.00%20.30%100% 27.03.2019CHF277.90280.69
/product/detail/index/isin/CH0241596680
24159668 
S&P 500 Index1'828.15 USD100.00%53.69%100% 11.04.2019USD2'756.712'774.99
/product/detail/index/isin/CH0245194391
24519439 
Roche275.56 CHF103.75%17.28%100% 28.05.2019CHF260.02262.63
/product/detail/index/isin/CH0259611330
25961133PPNEM
Newmont Mining24.46 USD119.50%66.84%100% 30.10.2019USD36.2036.40
/product/detail/index/isin/CH0286495939
28649593 
Aryzta49.33 CHF107.00%N/A100% 30.06.2020USD14.9715.44
/product/detail/index/isin/CH0291852827
29185282 
AstraZeneca / Glencore1'250.00 GBP125.00%49.21%100% 20.08.2018GBP1'959.421'969.42
/product/detail/index/isin/CH0293217326
29321732 
Barrick Gold10.20 USD151.00%68.09%100% 27.08.2020USD12.9513.02
/product/detail/index/isin/CH0293218589
29321858 
Swiss Re109.45 CHF132.50%44.24%100% 28.08.2020CHF102.33103.10
/product/detail/index/isin/CH0293218647
29321864 
Barrick Gold10.71 USD151.00%66.43%100% 28.08.2020USD13.0613.13
/product/detail/index/isin/CH0293218662
29321866 
Swiss Re109.45 CHF132.50%44.24%100% 27.08.2020CHF102.35103.12
/product/detail/index/isin/CH0319943343
31994334PEPNEU
Nestlé77.94 CHF109.00%31.76%100% 29.05.2019CHF80.2080.65
/product/detail/index/isin/CH0319943350
31994335 
Novartis81.98 CHF112.00%32.05%100% 29.04.2019CHF82.4183.24
/product/detail/index/isin/CH0332917589
33291758 
MSCI Emerging Markets Index / S&P 500 Index2'169.04 USD 44.50%100% 27.08.2018USD1'283.861'293.86
/product/detail/index/isin/CH0332921193
33292119 
S&P 500 Index2'164.25 USD 59.76%100% 04.08.2021USD2'702.032'723.67
  • 10 per page
  • 20 per page
  • 50 per page
  • 100 per page

Bonus certificate (UBS PERLES Plus)

UBS PERLES Plus or Bonus Certificates offer you attractive yield opportunities even if the underlying asset (e.g. equity or index) does not significantly gain in value as expected, since UBS PERLES Plus enable you to improve yields in sideways markets depending on the product features in addition to the unlimited earnings opportunity. As an investor, you participate unconditionally 1:1 in a potential positive performance of the underlying asset. In exchange for the dividend of the underlying asset, UBS PERLES Plus offers you conditional partial protection, i.e. should the underlying asset never be listed at or below a predefined barrier (kick-out level) during the term, a minimum repayment is effected at maturity, which corresponds to the predefined PERLES Plus bonus level.

However, this partial protection ceases to apply if a barrier is broken during the term. According to this, PERLES Plus behaves like a normal PERLES, i.e. investors also participate in a negative performance of the underlying asset 1:1 without restriction, and so losses are likely. UBS PERLES Plus is thus suitable for investors with a medium to high risk preference. Investors must take the issuer risk into consideration, since loss of the invested capital could occur if UBS AG becomes insolvent, regardless of the performance of the underlying asset.